DE60223040D1 - Epitop-untersuchung mit hla - Google Patents
Epitop-untersuchung mit hlaInfo
- Publication number
- DE60223040D1 DE60223040D1 DE60223040T DE60223040T DE60223040D1 DE 60223040 D1 DE60223040 D1 DE 60223040D1 DE 60223040 T DE60223040 T DE 60223040T DE 60223040 T DE60223040 T DE 60223040T DE 60223040 D1 DE60223040 D1 DE 60223040D1
- Authority
- DE
- Germany
- Prior art keywords
- epitop
- hla
- study
- peptide
- assaying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4728—Calcium binding proteins, e.g. calmodulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1247—DNA-directed RNA polymerase (2.7.7.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/605—MHC molecules or ligands thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27460501P | 2001-03-09 | 2001-03-09 | |
US274605P | 2001-03-09 | ||
US974366 | 2001-10-10 | ||
US09/974,366 US7541429B2 (en) | 2000-10-10 | 2001-10-10 | Comparative ligand mapping from MHC positive cells |
US10/022,066 US20030166057A1 (en) | 1999-12-17 | 2001-12-18 | Method and apparatus for the production of soluble MHC antigens and uses thereof |
US22066 | 2001-12-18 | ||
US36279902P | 2002-03-07 | 2002-03-07 | |
US362799P | 2002-03-07 | ||
PCT/US2002/007121 WO2002072606A2 (en) | 2001-03-09 | 2002-03-08 | Epitope testing using hla |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60223040D1 true DE60223040D1 (de) | 2007-11-29 |
DE60223040T2 DE60223040T2 (de) | 2008-07-31 |
Family
ID=27487068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60223040T Expired - Lifetime DE60223040T2 (de) | 2001-03-09 | 2002-03-08 | Epitop-untersuchung mit hla |
Country Status (7)
Country | Link |
---|---|
US (4) | US20030124613A1 (de) |
EP (1) | EP1417487B1 (de) |
AT (1) | ATE376184T1 (de) |
AU (1) | AU2002252253A1 (de) |
CA (1) | CA2440399C (de) |
DE (1) | DE60223040T2 (de) |
WO (1) | WO2002072606A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090062512A1 (en) * | 2000-10-10 | 2009-03-05 | Hildebrand William H | Comparative ligand mapping from MHC class I positive cells |
US20070099182A1 (en) * | 2000-10-10 | 2007-05-03 | Hildebrand William H | Comparative ligand mapping from MHC class I positive cells |
US20070026433A1 (en) * | 2001-03-09 | 2007-02-01 | Hildebrand William H | Epitope testing using soluble HLA |
US6867283B2 (en) | 2001-05-16 | 2005-03-15 | Technion Research & Development Foundation Ltd. | Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells |
US20040072262A1 (en) * | 2002-10-11 | 2004-04-15 | Montero-Julian Felix A. | Methods and systems for detecting MHC class I binding peptides |
US7309589B2 (en) * | 2004-08-20 | 2007-12-18 | Vironix Llc | Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing |
US9488645B2 (en) * | 2005-09-09 | 2016-11-08 | Jianhui Rong | Cell-based microarrays and methods of use |
GB2430256B (en) * | 2005-09-19 | 2008-06-25 | Proimmune Ltd | A method of screening MHC molecules |
US20120077696A1 (en) * | 2009-03-15 | 2012-03-29 | Technion Research And Development Foundation Ltd. | Soluble hla complexes for use in disease diagnosis |
US10857219B2 (en) | 2014-03-28 | 2020-12-08 | The Board Of Regents Of The University Of Oklahoma | Compositions comprising soluble HLA/M. tuberculosis-specific ligand complexes and methods of production and use thereof |
WO2017185169A1 (en) | 2016-04-27 | 2017-11-02 | University Health Network (Uhn) | Pept1de-hla complexes and methods of producing same |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
FI890312A (fi) * | 1988-01-25 | 1989-07-26 | Oncogen | Amfiregulin: ett nytt bifunktionellt tillvaext modulerande glykoprotein. |
US5256541A (en) * | 1991-11-06 | 1993-10-26 | Sangstat Medical Corporation | Detection of soluble alloantigen immune complexes |
US5292641A (en) * | 1991-12-13 | 1994-03-08 | Sangstat Medical Corporation | Alloantigen testing by binding assay |
US5583031A (en) * | 1992-02-06 | 1996-12-10 | President And Fellows Of Harvard College | Empty major histocompatibility class II heterodimers |
US6001365A (en) * | 1992-02-19 | 1999-12-14 | The Scripps Research Institute | In vitro activation of cytotoxic T cells |
US5270169A (en) * | 1992-06-23 | 1993-12-14 | Sangstat Medical Corporation | Detection of HLA antigen-containing immune complexes |
US5750367A (en) * | 1993-11-08 | 1998-05-12 | Baylor College Of Medicine | Human and mouse very low density lipoprotein receptors and methods for use of such receptors |
US5482841A (en) * | 1994-05-24 | 1996-01-09 | Sangstat Medical Corporation | Evaluation of transplant acceptance |
GB9414938D0 (en) * | 1994-07-25 | 1994-09-14 | Boc Group Plc | Air separation |
DK0814838T3 (da) * | 1995-03-08 | 2003-09-15 | Scripps Research Inst | Antigenpræsenterende system og aktivering af T-celler |
US5776746A (en) * | 1996-05-01 | 1998-07-07 | Genitope Corporation | Gene amplification methods |
US5710248A (en) * | 1996-07-29 | 1998-01-20 | University Of Iowa Research Foundation | Peptide tag for immunodetection and immunopurification |
US6232445B1 (en) * | 1997-10-29 | 2001-05-15 | Sunol Molecular Corporation | Soluble MHC complexes and methods of use thereof |
US6867283B2 (en) * | 2001-05-16 | 2005-03-15 | Technion Research & Development Foundation Ltd. | Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells |
-
2002
- 2002-03-08 WO PCT/US2002/007121 patent/WO2002072606A2/en active IP Right Grant
- 2002-03-08 EP EP02721315A patent/EP1417487B1/de not_active Expired - Lifetime
- 2002-03-08 DE DE60223040T patent/DE60223040T2/de not_active Expired - Lifetime
- 2002-03-08 AU AU2002252253A patent/AU2002252253A1/en not_active Abandoned
- 2002-03-08 CA CA002440399A patent/CA2440399C/en not_active Expired - Lifetime
- 2002-03-08 AT AT02721315T patent/ATE376184T1/de not_active IP Right Cessation
- 2002-03-11 US US10/095,818 patent/US20030124613A1/en not_active Abandoned
-
2005
- 2005-10-24 US US11/257,286 patent/US20060040310A1/en not_active Abandoned
-
2010
- 2010-11-02 US US12/938,071 patent/US20110065587A1/en not_active Abandoned
-
2012
- 2012-08-13 US US13/584,386 patent/US20120329670A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE60223040T2 (de) | 2008-07-31 |
EP1417487B1 (de) | 2007-10-17 |
US20030124613A1 (en) | 2003-07-03 |
ATE376184T1 (de) | 2007-11-15 |
US20060040310A1 (en) | 2006-02-23 |
EP1417487A4 (de) | 2005-04-27 |
US20120329670A1 (en) | 2012-12-27 |
WO2002072606A3 (en) | 2004-03-04 |
WO2002072606A2 (en) | 2002-09-19 |
AU2002252253A1 (en) | 2002-09-24 |
CA2440399A1 (en) | 2002-09-19 |
CA2440399C (en) | 2008-11-18 |
US20110065587A1 (en) | 2011-03-17 |
EP1417487A2 (de) | 2004-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60223040D1 (de) | Epitop-untersuchung mit hla | |
MA30922B1 (fr) | Anticorps d'agonistes de trkb et leurs utilisations | |
ES2192157T1 (es) | Metodo y dispositivo para determinacion de posicion. | |
BR0111731A (pt) | Ensaio de combinação de anticorpo/antìgeno do hcv | |
DE60334459D1 (de) | Belastungsmesssystem | |
NO20015096D0 (no) | Måling og bruk av molekul¶re interaksjoner | |
BRPI0503644A (pt) | método e aparelho para o aperfeiçoamento da fala por múltiplos sensores em um dispositivo móvel | |
TW200616578A (en) | Fluid handling devices | |
ATE437370T1 (de) | Pharmakodynamische tests mit durchflusszytometrie | |
AU2003224447A1 (en) | Device and method to simultaneously detect different antibodies and antigens in clinical alimentary and environmental samples | |
ATE378399T1 (de) | Magnetische manipulation von biologischen proben | |
DE102005023067A8 (de) | Vorrichtung zur Prüfung der Dichtungsbelastbarkeit | |
ATE463722T1 (de) | Konfokale flüssigkeitsstandmessung | |
DE59803030D1 (de) | Messwerk, insbesondere für anzeigeeinrichtungen in der kfz-technik | |
ATE367352T1 (de) | Prüfhebel | |
ATE467128T1 (de) | Kolloidale metallkonjugate | |
DE60201353D1 (de) | Verbessertes anzeigebauelement | |
DE602004015953D1 (de) | Festphase immunochromatographische testverfahren | |
ATE319985T1 (de) | Gerät zur inspektion von versiegelten verpackungen | |
SE9901022D0 (sv) | Belysningsanordning | |
DK1257830T3 (da) | Assay til måling af holo-transcobalamin og folat | |
DE59803219D1 (de) | Messwerk, insbesondere für anzeigeeinrichtung in der kfz-technik | |
ITMI20022436A1 (it) | Dispositivo per la misurazione della sensibilita' barestesica. | |
BRPI0418183A (pt) | ensaios bioluminescentes e células úteis nos mesmos | |
DE502004008567D1 (de) | Messschlitten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |